Company Performance Metrics
Michael T. Falduto: Founder,CEO & CTO
Paradise Genomics is a biotech company providing unparalleled utility in the diagnosis, prognosis, or therapeutic monitoring of any disease. The company discovers the most complete gene expression signatures for earlier, more accurate, and less intrusive detection of human diseases. Their disruptive approach and process provide unparalleled utility
in the diagnosis, prognosis, or therapeutic monitoring of any disease.
Paradise Genomics provides a technology platform for identifying gene expression signatures intended to bring improvements in diagnostics, drug discovery, and management of the disease. The company's genomic platform offers genomic data for product development, enabling the healthcare industry to discover gene expression signatures in blood and diseased tissues.
It was founded in 2012 and is headquartered in Northbrook, Illinois, USA.
